These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22495990)

  • 21. Recent perspectives on the diagnosis and treatment of generalized anxiety disorder.
    Ninan PT
    Am J Manag Care; 2001 Sep; 7(11 Suppl):S367-76. PubMed ID: 11570027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sooner or later: age at onset of generalized anxiety disorder in older adults.
    Gonçalves DC; Byrne GJ
    Depress Anxiety; 2012 Jan; 29(1):39-46. PubMed ID: 21898708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generalized anxiety disorder: between now and DSM-V.
    Allgulander C
    Psychiatr Clin North Am; 2009 Sep; 32(3):611-28. PubMed ID: 19716993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder.
    Beesdo K; Pine DS; Lieb R; Wittchen HU
    Arch Gen Psychiatry; 2010 Jan; 67(1):47-57. PubMed ID: 20048222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Well-being and life satisfaction in generalized anxiety disorder: comparison to major depressive disorder in a community sample.
    Stein MB; Heimberg RG
    J Affect Disord; 2004 Apr; 79(1-3):161-6. PubMed ID: 15023490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Varying temporal criteria for generalized anxiety disorder: prevalence and clinical characteristics in a young age cohort.
    Angst J; Gamma A; Joseph Bienvenu O; Eaton WW; Ajdacic V; Eich D; Rössler W
    Psychol Med; 2006 Sep; 36(9):1283-92. PubMed ID: 16734945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association between social isolation and DSM-IV mood, anxiety, and substance use disorders: wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.
    Chou KL; Liang K; Sareen J
    J Clin Psychiatry; 2011 Nov; 72(11):1468-76. PubMed ID: 21295001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The co-occurrence of DSM-IV alcohol abuse in DSM-IV alcohol dependence: results of the National Epidemiologic Survey on Alcohol and Related Conditions on heterogeneity that differ by population subgroup.
    Hasin DS; Grant BF
    Arch Gen Psychiatry; 2004 Sep; 61(9):891-6. PubMed ID: 15351767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel approaches to treatment of generalized anxiety disorder.
    Allgulander C
    Curr Opin Psychiatry; 2010 Jan; 23(1):37-42. PubMed ID: 19890214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generalizability of clinical trials for cannabis dependence to community samples.
    Okuda M; Hasin DS; Olfson M; Khan SS; Nunes EV; Montoya I; Liu SM; Grant BF; Blanco C
    Drug Alcohol Depend; 2010 Sep; 111(1-2):177-81. PubMed ID: 20537813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generalizability of Clinical Trial Results for Adolescent Major Depressive Disorder.
    Blanco C; Hoertel N; Franco S; Olfson M; He JP; López S; González-Pinto A; Limosin F; Merikangas KR
    Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29097612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychological and pharmacological treatments for generalized anxiety disorder (GAD): a meta-analysis of randomized controlled trials.
    Carl E; Witcraft SM; Kauffman BY; Gillespie EM; Becker ES; Cuijpers P; Van Ameringen M; Smits JAJ; Powers MB
    Cogn Behav Ther; 2020 Jan; 49(1):1-21. PubMed ID: 30760112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interpersonal dysfunction and treatment outcome in GAD: A systematic review.
    Malivoire BL; Mutschler C; Monson CM
    J Anxiety Disord; 2020 Dec; 76():102310. PubMed ID: 33002755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols.
    Gandhi M; Ameli N; Bacchetti P; Sharp GB; French AL; Young M; Gange SJ; Anastos K; Holman S; Levine A; Greenblatt RM
    AIDS; 2005 Nov; 19(16):1885-96. PubMed ID: 16227797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in anxiety management.
    Yates WR; Wesner RB
    J Am Board Fam Pract; 1989; 2(1):37-42. PubMed ID: 2646853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials.
    van Eijk RPA; Westeneng HJ; Nikolakopoulos S; Verhagen IE; van Es MA; Eijkemans MJC; van den Berg LH
    Neurology; 2019 Jan; 92(5):e451-e460. PubMed ID: 30626653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of study criteria on recruitment and generalizability of the results.
    Khan AY; Preskorn SH; Baker B
    J Clin Psychopharmacol; 2005 Jun; 25(3):271-5. PubMed ID: 15876909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychotherapy Treatment of Generalized Anxiety Disorder Improves When Conducted Under Narrow Band Green Light.
    Melo-Carrillo A; Rodriguez R; Ashina S; Lipinski B; Hart P; Burstein R
    Psychol Res Behav Manag; 2023; 16():241-250. PubMed ID: 36726697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing and Contrasting A Priori and A Posteriori Generalizability Assessment of Clinical Trials on Type 2 Diabetes Mellitus.
    He Z; Gonzalez-Izquierdo A; Denaxas S; Sura A; Guo Y; Hogan WR; Shenkman E; Bian J
    AMIA Annu Symp Proc; 2017; 2017():849-858. PubMed ID: 29854151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Examination of participant flow in the CONSORT diagram can improve the understanding of the generalizability of study results.
    Andrade C
    J Clin Psychiatry; 2015 Nov; 76(11):e1469-71. PubMed ID: 26646042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.